A South Korean government-certified bio-venture Naturalendo has distinctive competitiveness in the production of bio science, herbs and endocrinology in the global market. Established in 2001, the company has developed antagonistic formula against dioxin, phytoestrogen, IGF-1 secretagogue, and a blood sugar lowering herbal formula.

The most successful result was EstroG-100, a supplement designed to reduce the symptoms of menopause. Its efficacy has been compared to hormone replacement therapy but without the potential side-effects. The ingredients of EstroG-100 include Cynanchumwilfordii, Phlomisumbrosa, and Korean Angelica. By screening 71 different medicine herbs, the company could select the three herbs supposed to carry effectiveness on women’s health in traditional herbal medicine.

Women are supposed to suffer from various hormone imbalance symptoms including hot flush, night sweat, insomnia, depression which are mainly due to the decrease of the Estrogen level in their bodies from, on average, age 35 up to menopause.

EstroG-100, its natural herbal extracts, provide relief averaging 62% in 10 typical menopausal symptoms efficiently without any side effects while other products improve 1~2 symptoms with side effects. EstroG-100 also improves bone metabolism and bone density. The EstroG-100 received the Health Canada Product License, Worldclass Product Award from the Ministry of KnowledgeEconomy, and Presidential Citation for contribution to the national industry in 2011. EstroG-100 also won Korean FDA approval and NDI from the FDA in 2010.

• Naturalendo Tech Co., Ltd.

E-201, Pankyo Inno Valley, 622, Sampyung-dong, Bundang-gu, Sungnam, Gyeonggi-do, Korea
Tel: (82-70)4601-3152
Fax: (82-70)4601-3154
E-mail: yekim@naturalendo.co.kr
Website: naturalendo.co.kr